| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |